A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to assess the efficacy and safety of the national
malaria treatment guidelines, asses the efficacy and safety of artesunate and sulphadoxine -
pyrimethamine (AS+SP) for treatment in uncomplicated P. falciparum and P. vivax malaria and
the hematologic effect of 14 days routine primaquine based radical cure in patients suffering
from a P. vivax or mixed infection.